This investigation was designed to determine whether nano-sized manganese oxide , which is known to induce concentration-dependent dopamine depletion. There was a significant increase (>10-fold) in reactive oxygen species (ROS) with Mn-40 nm exposure suggesting that increased ROS levels may participate in dopamine depletion. These results clearly demonstrate that nanoscale manganese can deplete dopamine, DOPAC, and HVA in a dose-dependent manner. Further study is required to evaluate the specific intracellular distribution of Mn-40nm nanoparticles, metal dissolution rates in cells and cellular matrices, if dopamine depletion is induced in vivo, and the propensity of Mn nanoparticles to cross the blood brain barrier or be selectively uptaken by nasal epithelium.
Abstract:
This investigation was designed to determine whether nano-sized manganese oxide (Mn-40nm) particles would induce dopamine (DA) depletion in a cultured neuronal phenotype, PC-12 cells, similar to free ionic manganese (Mn 2+ ). Cells were exposed to dose-dependently depleted dopamine (DA) and its metabolites, dihydroxyphenylacetic acid (DOPAC) and homovanillic acid (HVA), while Ag-15nm only significantly reduced DA and DOPAC at concentrations of 50 μg/ml. Therefore, the dopamine depletion of Mn-40nm was most similar to Mn
2+
, which is known to induce concentration-dependent dopamine depletion. There was a significant increase (>10-fold) in reactive oxygen species (ROS) with Mn-40 nm exposure suggesting that increased ROS levels may participate in dopamine depletion. These results clearly demonstrate that nanoscale manganese can deplete dopamine, DOPAC, and HVA in a dose-dependent manner. Further study is required to evaluate the specific intracellular distribution of Mn-40nm nanoparticles, metal dissolution rates in cells and cellular matrices, if dopamine depletion is induced in vivo, and the propensity of Mn nanoparticles to cross the blood brain barrier or be selectively uptaken by nasal epithelium.
Introduction:
Nanotechnology involves the creation and manipulation of materials at the nanoscale level to produce unique products with novel properties. Nanomaterials, which are functionally defined as having a single dimensional feature within the range of 1 -100 nanometers range, have been used to create materials that exhibit novel physicochemical properties and function imparted through this engineered, controlled feature size.
Nanomaterials such as nanotubes, nanowires, fullerene derivatives (buckyballs), and quantum dots have received enormous national attention for creating new consumer products as well as advancing science with novel analytical tools for both physical and life sciences (Wu and Bruchez 2004; Taton, et al. 2000; Cui and Gao 2003) . Examples include the synthesis and use of uniformly sized magnetic nanoparticles for magnetic storage media, ferrofluids, magnetic resonance imaging (MRI), and magnetically guided drug delivery. Nanomaterials are of interest to the Air Force because of their potential use in multiple advanced systems for applications including electronics, sensors, and energy production.
Man-made nanoparticles and materials are rapidly being produced in large quantities throughout the world. With the increased probability of exposure from large-yield industry production, the issue of toxicity has lead to new investigations of dosing and exposure to elemental metals. Although a wide and growing number of applications for nanomaterials exist, there is a serious lack of information concerning the human health and environmental implications of these manufactured nanomaterials. Limited studies assessing the toxicity of man-made nanomaterials are available that provide an initial risk assessment of nanomaterials through the extension of exposure data from research models (Oberdörster 2004; Hussain, et al. 2005; Monteiro-Riviere, et al. 2004; Lam et al. 2004; Braydich, et al. 2005) . Lam et al. (2004) demonstrated that carbon nanotube products induced dose-dependent epithelial granulomas in mouse lungs and, in some cases, deep lung interstitial inflammation occurred in the animals 7-days post-exposure.
A study by Oberdörster et al. (2004) indicated that fullerenes (C 60 ) induced oxidative stress in the fish brain. Multi-walled carbon nanotube interactions with human epidermal keratinocytes were studied by Monteiro-Riviere et al. (2005) , who found that nanotubes produced a toxic irritant response to cells by releasing pro-inflammatory cytokines.
However, a key issue presently overlooked in evaluating the utility and distribution of man-made nanomaterials is assessing their potential toxicity based on their inherent chemical composition (e.g. heavy metals), diverse level of carbon-based functionalization, and/or nanoscale chemically stable properties. Therefore, further critical science-based processes must be considered to assure the safety of these nanomaterials after primary exposure such as those encountered by individuals working with these materials and secondary exposure by individuals such as consumers. Studies from our laboratory with in vitro models to evaluate potential toxicity screening of nanomaterials have indicated that nanomaterials such as silver (Ag-15 & 100 nm) showed significant toxicity in liver cells compared to controls . Recently, Ag nanoparticles have been used as antimicrobial agents and in wound care applications (Furno 2004 ).
Human studies have indicated that elevated levels of Mn may put humans at risk for
Parkinsonism (Olanow 2004) . This suggests that there may be a significant pathological consequences and risks to the central nervous system (CNS) when manufacturing nanoscale metals. Larger amounts of manganese metal or powder applications are typically found in industries involving steel and non-steel alloy production, battery manufacture, colorants, pigments, ferrites, welding fluxes, fuel additives, catalysts, and metal coatings. Due to the recent development of nanomaterials, macro-sized-manganese particles are likely to be replaced by manganese nanoparticles. The applications of Mn nanomaterials are currently being pursued for catalysis and battery technology (Han, et al. 2005) .
Manganese (Mn) exposure is known to produce neurotoxicity in vitro and in animal models (Aschner, et al. 2005; Jayakumar, et al. 2004 . Additionally, Mn-40nm produces high levels of reactive oxygen species (ROS) which are much greater than the levels produced by either Mn 2+ or Ag-15nm, which suggests that dopamine depletion after incubation with Mn-40nm in PC-12 cells may be associated with oxidative stress.
Materials and Methods

Chemicals
Manganese oxide (Mn-40nm) and silver (Ag-15nm) nanoparticles were generous 
Cell culture
The PC-12 cell line, derived from rattus norvegicus pheochromocytoma (CRL-1721), was obtained from American Type Tissue Culture (http://www.atcc.org). PC-12 cells were grown in RPMI-1640 media supplemented with 5% fetal bovine serum and 10%
horse serum (both heat inactivated), and 1% penicillin-streptomycin in a humidified atmosphere with 5% CO 2 at 37°C. The cells were cultured on rat-tail collagen coated flasks, plates, and slides. PC-12 cells are a neuroendocrine cell line with a capability to produce and excrete the neurotransmitter dopamine. This cell line can be used as a model cell for testing dopamine depletion. Cells were cultured by plating at densities to produce an 80% culture substrate confluency after 24 hours when they were then used for exposure studies.
Dispersion of nanomaterials in solution
Relatively homogeneous nanoparticle dispersions (10 mg/ml stock solutions) were prepared by brief sonication (Cole-Parmer 470 50W ultrasonic tip processor). Ag-15nm
particles were dispersed in sterile de-ionized water and both Mn-40nm nanoparticles and
Mn acetate in physiological saline. From these stock solutions, different final concentrations ranging from 1 to 100µg/ml were prepared in cell growth medium (RPMI-1640). However, the preparation of relatively homogenous dispersions of nanomaterial dilutions from the stock solutions into cell culture media is an issue that has not yet been satisfactorily resolved. Both Ag15-nm and Mn-40nm tend to agglomerate, which may not change the chemical nature of the nanoparticles, but may impact the actual size of particle interacting with the cells and its associated cytotoxicity. The addition of a detergent such as 1% TWEEN-20 appears to enable homogenous dispersion ( Figure 1 ).
However, due to the adverse effects of TWEEN-20 on PC-12 cell viability, this agent was not used in these experiments.
Transmission electron microscopy (TEM) of Mn-40nm Nanoparticles
Transmission electron microscopy (TEM) characterization was performed on a Hitachi H-7600 tungsten-tip instrument at an accelerating voltage of 120kV. Mn-40nm
nanoparticles were examined after suspension in water and subsequent deposition onto formvar/carbon-coated TEM grids. The AMT software for the digital TEM camera was calibrated for size measurements of the nanoparticles. Information on mean size and standard deviation were calculated from a random field of view in addition to images that show agglomeration and general morphology of the nanoparticles (Figure 2 ).
Exposure protocol
PC-12 cells were grown for at least 24 hours until they reached 80% confluency in 6 well plates or two chambered slides. Then, they were treated with 1 to 100µg/ml of nanoparticles suspended in culture growth medium. After 24 hours of incubation, multiple toxicity end points were evaluated in control and nanoparticle-exposed cells.
Microscopic studies for morphological changes and uptake of nanoparticles.
After PC-12 cells were exposed to various concentrations of nanoparticles or soluble metal (Mn 2+ , AgNO 3 ) for 24 hours, cells (control and exposed), were washed with PBS, slide chambers were removed, cover slips were placed on the slides, and the edges of the cover slips were sealed with clear nail polish to avoid the movement of cover slips while examining under the microscope. Morphological changes were observed with phase contrast inverted microscopy at 20x magnification ( Figure 3 ). Uptake and interaction of Mn-40nm was also examined on an Olympus inverted light microscope modified with the CytoViva150 Ultra Resolution Imaging (URI) system with advanced optical illumination at 60x (Figure 4 ). This improved the microscope resolution in order to observe particles as small as 100nm in size. The microscope pictures were captured by using QCapture Pro Imaging software.
Cytotoxicity endpoints
Cell viability was determined by the MTT assay for mitochondrial function (Carmichael, et al. 1987 ) with a slight modification, which is based on the conversion of tetrazolium salt into an insoluble formazan product by various dehydrogenases in mitochondria. PC-12 cells were plated at approximately one million cells per ml, grown to 80% confluency, and exposed to various concentrations of nanoparticles (1-100µg/ml) for 24 hours. At the end of incubation, cells were treated with the MTT solution (final concentration, 1mg/ml) for 30 minutes at 37ºC in a cell culture incubator. The resulting formazan blue colored product was dissolved in 1 ml of acidified isopropanol and the absorbance was measured at 570 nm by using a SpectraMax, Microplate Reader (Molecular Devices).
Determination of dopamine and its metabolites
Following nanoparticle or metal ion treatment, the cells were homogenized in 0.2N perchloric acid (20% w/v) containing an internal standard (3, 4-dihydroxybenzylamine; 100ng/ml). The homogenates were centrifuged at 4 o C (13,000 x g; 10 min) and 300μl of the supernatant was removed and filtered through a 0.45 nylon centrifuge tube filter (Costar #8170). Aliquots of 25μl were injected directly into the HPLC/electrochemical detection system for separation of analytes (Hussain and Ali 2002) . The amount of DA, DOPAC, and HVA were calculated using standard curves that were generated by determining, in triplicate, the ratio between three different known amounts of the amine or its metabolites compared to a constant amount of internal standard.
Dichlorofluorescein (DCF) assay for reactive oxygen species (ROS).
Reactive oxygen species (ROS) generation was determined using the method described by Wang and Joseph (1999) . Viable cells (10 4 /well) were plated into 96-well collagen-coated plates 1 day before the experiments. On the day of the experiments, after removing the medium, the cells were incubated with 100 μM DCFH-DA in the growth medium at 5% CO 2 /95% air at 37°C for 30 minutes. After the DCFH-DA was removed, 
Statistical evaluation
The data were expressed as mean ± standard deviation (SD) of three independent experiments. Wherever appropriate, the data were subjected to statistical analysis by one-way analysis of variance (ANOVA) followed by Dunnett's Method for multiple comparisons. A value of p < 0.05 was considered significant. SigmaStat for Windows (version 2.03) software was used for the statistical analysis.
Results:
Initially, a test was conducted to determine the appropriate solution for the best dispersion of the nanoparticles. From the dispersion tests, the optimal solution for particle dissemination was heavily dependent upon the type of particle. Through these tests, we concluded the optimal medium for Mn-40nm nanoparticles was physiological saline and for Ag-15nm nanoparticles was de-ionized water. In conducting these tests, we observed the miscibility of nanoparticles in stock solutions, dispersion in culture media both with and without serum, and the pH of the resulting exposure treatment. The pH of both silver and manganese nanoparticles dispersed in exposure media resulted in a consistent pH between 7.0-7.4. The solution was turbid with increasing concentrations which is likely to be a result of nanoparticle agglomeration. In order to verify the Mn40nm nanoparticle size, morphology, dispersion state, and extent of agglomeration, we observed nanoparticle solutions under a microscope equipped with the CytoViva150
Ultra Resolution Imaging (URI) system for enhanced resolution. Figure 1A shows groups of agglomerated particles in normal physiological solution. However, when 0.1% surfactant (TWEEN-20) was added, most of the particles appeared to be dispersed ( Figure 1B) .
A 1 mg/ml solution of Mn-40nm nanoparticles suspended in water was also examined with bright-field transmission electron microscopy (TEM) for size, morphology, and dispersion state (agglomeration) as shown in Figure 2A -C. Some areas of the TEM grid had micron-sized Mn agglomerates ranging in size from 1 micron to over 10 microns.
An agglomerate measuring 1.38 microns at 15,000x is shown in Figure 2A .
However, other areas on the TEM grid showed less agglomeration or even individual nanoparticles at magnifications of 60, 000x and 50, 000x, respectively ( Figure 2B and C). The Mn-40nm nanoparticles were irregular in shape and could readily be measured and ranged in size from 24.3 nm to 56.9 with an average size of 38.9 nm and a standard deviation of 11.58 nm taken from 10 individual nanoparticles in Figure 2C . It is possible that the morphologies and agglomeration state of the nanoparticles changes with in vitro conditions such as incubation in cell culture media and entry into the cells. However, these changes cannot be accurately captured by suspending the materials in PBS, dispersing them onto a TEM grid, and allowing them to dry before imaging. In this case, the TEM images in Figure 2 only represent the primary particle size of the Mn40nm as well as nanoparticle aggregation found under these conditions. Therefore, in this respect, the light microscope images provide the strongest evidence for liquid-phase agglomeration that would be most similar to in vivo conditions and the TEM images provide higher magnification data on the primary particle size and shape.
The morphologies of control, Mn-40nm, Ag-15nm, and Mn acetate (Mn with silver nanoparticles or silver nitrate (AgNO 3 ) appeared to be decreased in size with irregularities in their shape. Therefore, the morphological effect of Mn-based solutions at the same dose (50µg/ml) as silver-based solutions was less pronounced.
In the present study, the CytoViva150 Ultra Resolution Imaging (URI) system was also used to follow the uptake, translocation, and distribution of nano-sized Mn particles in PC-12 cells under physiological conditions. Representative images of cells containing Mn-40nm after doses of 50µg/ml are shown in Figure 4A -C. These experimental results demonstrate that Mn-40nm nanoparticles and agglomerates are effectively internalized by PC-12 cells. Additionally, bright aggregates were found attached to the outer portions of the cells. As expected, aggregation is an intrinsic property of these particles in solution.
Further studies are under investigation to characterize the dynamic properties of these particles/aggregates such as their true size distribution in solution and inside cells.
A significant dose-dependent decrease in mitochondrial function was observed after PC-12 cells were exposed to the nanometals in this study at doses ranging from 10-50 μg/ml compared to control, untreated cells ( Figure 5 ). This result differed from the complete lack of PC-12 mitochondrial function loss after 24hr exposure (data not shown) with 5-100 μg/ml fine carbon black as a positive control particle. Ag-15nm displayed a significant depletion of DA only at a highly toxic dose of 50μg/ml, which was likely due to loss of cellular function rather than dopamine pathway disruption ( Figure 6A ). DOPAC concentration was significantly depleted in all administered doses (5-50 μg/ml) of Mn-40nm and Mn 2+ ( Figure 6B ). However, with Ag-15nm, there was a significant decrease again only at the 50μg/ml dose ( Figure 6B ). There were no significant changes in HVA levels after cells were incubated with concentrations from 5-10μg/ml of Mn-40nm or Mn 2+ while there were significant depletions of HVA at doses of 50μg/ml for both Mn-based solutions.
The ROS levels were measured to examine the involvement of oxidative stress in Mn-40nm toxicity ( Figure 7A-C ). It appears that Mn-40nm induces a 10-fold or greater increase in ROS levels whereas Mn acetate (Mn
2+
) and Ag-15nm only induce a 3-fold or greater increase in ROS levels relative to the basal control levels. Therefore, the production of ROS in PC-12 cells incubated with Mn-40nm is much higher than both Mn 2+ and Ag-15nm exposed cells.
Discussion:
Despite the many applications of nanomaterials, some studies indicate that certain nanoparticles may adversely affect human health due to their small size, reactive properties, and high surface area to material amount/weight. Indeed, their small size and large surface area may allow them to readily gain entry into cells and tissues. Some nanoparticles may enter through inhalation, into the nose or lungs, or through ingestion entering the digestive system. Once in the body due to their minute size, nanoparticles may translocate to sites distant from their portal of entry (Oberdorster, et al. 2005 ). Such translocation is facilitated by the propensity of nanoparticles to enter cells, cross cell membranes, and move within or along the axons and dendrites that connect neurons.
Nanoparticles have been shown to enter the brain via the nervus olfactorius after deposition on the olfactory mucosa of the nose following instillation or inhalation (Oberdörster, et al. 1995) . This preferential toxicodynamic distribution of nanoparticles in the nasal passage increases the central nervous system entry potential and the potential for metal particulate toxicity to sensitive neurons within the CNS.
This study was designed to evaluate whether nanoscale particles (<100nm), such as Mn-40nm and Ag-15nm, induced toxicity in a neuroendocrine cell line (PC-12) when compared to the known neurotoxin manganese ion (Mn   2+   ) . For toxicity evaluations, cellular morphology, mitochondrial function (MTT assay), and dopamine/its metabolites were assessed at 24 hours after exposure to doses of nanoparticles or metal ions and compared to unexposed cells. PC-12 cells have been used as an in vitro model system to demonstrate that sub-micromolar concentrations of Mn 2+ induce extracellular dopamine depletion (Alinovi, et al. 1996) . Manganese (Mn) is an essential element during brain development (Hurley 1981) , but it can be toxic and lead to neurological symptoms mimicking Parkinsonism. Manganese induces neurotoxicity by interacting with basal ganglia, selectively depleting striatal dopamine (Archibald and Tyree 1987) , and generating oxidative stress (Hussain, et al. 1997; Simonian and Coyle 1996) , which may play an important role in Mn-induced neuronal degeneration. However, it is not yet known whether Mn nanoparticles produced effects similar to its soluble counterpart
The most important characteristics of nanoparticles are their size, surface area, and reactivity. One property of nanoparticles not well-considered in toxicity, but wellconsidered for therapeutic use, is the dissolution of materials after delivery into the cells.
Therefore, in addition to the ease of entry and immense surface areas delivered in a dose, The dopamine depletion induced by Mn-40nm and Mn 2+ was also compared with another nanoparticle, Ag-15nm, known to exhibit toxicity in other cell lines (Braydich-Stolle et al, 2005; Hussain et al., 2005) . Our previous results indicated that Ag-15nm can induce toxicity, in part, through oxidative stress in liver cells . In this study, our results show that Ag-15nm did not deplete dopamine except at a high and cytotoxic dose (50 µg/ml). It is clear that both Mn-40nm and Mn 2+ induced dopamine depletion and caused a reduction in its metabolites in a dose-dependent manner ( Figure   6 ). Our results also clearly demonstrated that Mn-40nm induced ROS at significantly greater amounts compared to Ag-15nm or Mn
2+
. It is possible that the increased production of ROS could be due to the generation or direct interaction of oxidized dopamine metabolites with DCFH-DA. Other studies have shown manganese ions can directly oxidize monoamines such as serotonin and dopamine (Lloyd 1995; SeguraAguilar and Lind 1989) or that the products of monoamine oxidation may covalently link to serotonin-binding protein (Velez-Pardo, et al. 1997 , 1998 . It is currently unknown whether Mn-40nm selectively interferes with dopamine metabolism through ROS production, depletion of dopamine by interfering with metabolic pathways/select enzymes (tyrosine hydroxylase) involved in dopamine synthesis, or through the direct oxidation of dopamine metabolites. There may be both enzymatic (e.g., tyrosine
hydroxylase inhibition) and non-enzymatic (direct oxidation) mechanisms that may underlie these reductions in cellular dopamine and dopamine metabolite levels (Almas, et al. 1992 ). However, this significant increase in ROS is noteworthy and is under further investigation.
Manganese is a well recognized neurotoxin that produces symptoms such as diminished motor skills and psychological disturbances, which parallel those of Nonetheless, the extent to which the dramatic effect of manganese on DA neurotransmitters observed here extrapolates to animals or humans remains to be shown.
Presently we are evaluating the depletion of dopamine by Mn-40nm in an animal model to assess if these nanoparticles can cross the blood brain barrier or gain entry into the brain through the olfactory bulb neuroprocesses. 
